Literature DB >> 16838299

The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention.

Miguel Stevens1, Erik De Clercq, Jan Balzarini.   

Abstract

The regulation of transcription of the human immunodeficiency virus (HIV) is a complex event that requires the cooperative action of both viral and cellular components. In latently infected resting CD4(+) T cells HIV-1 transcription seems to be repressed by deacetylation events mediated by histone deacetylases (HDACs). Upon reactivation of HIV-1 from latency, HDACs are displaced in response to the recruitment of histone acetyltransferases (HATs) by NF-kappaB or the viral transcriptional activator Tat and result in multiple acetylation events. Following chromatin remodeling of the viral promoter region, transcription is initiated and leads to the formation of the TAR element. The complex of Tat with p-TEFb then binds the loop structures of TAR RNA thereby positioning CDK9 to phosphorylate the cellular RNA polymerase II. The Tat-TAR-dependent phosphorylation of RNA polymerase II plays an important role in transcriptional elongation as well as in other post-transcriptional events. As such, targeting of Tat protein (and/or cellular cofactors) provide an interesting perspective for therapeutic intervention in the HIV replicative cycle and may afford lifetime control of the HIV infection. (c) 2006 Wiley Periodicals, Inc

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838299      PMCID: PMC7168390          DOI: 10.1002/med.20081

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  227 in total

Review 1.  Chromatin remodeling by RNA polymerases.

Authors:  Vasily M Studitsky; Wendy Walter; Maria Kireeva; Mikhail Kashlev; Gary Felsenfeld
Journal:  Trends Biochem Sci       Date:  2004-03       Impact factor: 13.807

2.  RNA recognition by Tat-derived peptides: interaction in the major groove?

Authors:  K M Weeks; D M Crothers
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

3.  Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein.

Authors:  J Hauber; M H Malim; B R Cullen
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein.

Authors:  M O Hottiger; G J Nabel
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter.

Authors:  A Henderson; M Bunce; N Siddon; R Reeves; D J Tremethick
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.

Authors:  Guocheng He; David M Margolis
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

7.  TFIIF-associating carboxyl-terminal domain phosphatase dephosphorylates phosphoserines 2 and 5 of RNA polymerase II.

Authors:  Patrick S Lin; Marie-Francoise Dubois; Michael E Dahmus
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

8.  NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro.

Authors:  M J Pazin; P L Sheridan; K Cannon; Z Cao; J G Keck; J T Kadonaga; K A Jones
Journal:  Genes Dev       Date:  1996-01-01       Impact factor: 11.361

9.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.

Authors:  B Ensoli; L Buonaguro; G Barillari; V Fiorelli; R Gendelman; R A Morgan; P Wingfield; R C Gallo
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters.

Authors:  H Du; A L Roy; R G Roeder
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  40 in total

1.  Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA.

Authors:  David I Bryson; Wenyu Zhang; Patrick M McLendon; Theresa M Reineke; Webster L Santos
Journal:  ACS Chem Biol       Date:  2011-10-28       Impact factor: 5.100

Review 2.  Emergence of a complex relationship between HIV-1 and the microRNA pathway.

Authors:  Dominique L Ouellet; Isabelle Plante; Corinne Barat; Michel J Tremblay; Patrick Provost
Journal:  Methods Mol Biol       Date:  2009

3.  Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.

Authors:  Amy Davidson; Thomas C Leeper; Zafiria Athanassiou; Krystyna Patora-Komisarska; Jonathan Karn; John A Robinson; Gabriele Varani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-07       Impact factor: 11.205

4.  Small molecule-RNA targeting: starting with the fundamentals.

Authors:  Amanda E Hargrove
Journal:  Chem Commun (Camb)       Date:  2020-11-26       Impact factor: 6.222

5.  Small Molecule-Based Pattern Recognition To Classify RNA Structure.

Authors:  Christopher S Eubanks; Jordan E Forte; Gary J Kapral; Amanda E Hargrove
Journal:  J Am Chem Soc       Date:  2016-12-22       Impact factor: 15.419

6.  Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.

Authors:  Miguel Stevens; Michela Pollicita; Christophe Pannecouque; Erik Verbeken; Oriana Tabarrini; Violetta Cecchetti; Stefano Aquaro; Carlo Federico Perno; Arnaldo Fravolini; Erik De Clercq; Dominique Schols; Jan Balzarini
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

Review 7.  Synthetic small-molecule RNA ligands: future prospects as therapeutic agents.

Authors:  A Di Giorgio; M Duca
Journal:  Medchemcomm       Date:  2019-04-30       Impact factor: 3.597

8.  C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors.

Authors:  Roger Hunter; Yassir Younis; Clare I Muhanji; Tanith-Lea Curtin; Kevin J Naidoo; Melissa Petersen; Christopher M Bailey; Aravind Basavapathruni; Karen S Anderson
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

Review 9.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

10.  Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication.

Authors:  Masha Sorin; Jennifer Cano; Supratik Das; Sheeba Mathew; Xuhong Wu; Kelvin P Davies; Xuanling Shi; S-W Grace Cheng; David Ott; Ganjam V Kalpana
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.